Inactive Instrument

Company Loon Energy Corporation Toronto S.E.

Equities

LNE.H

CA5435123057

Biotechnology & Medical Research

Business Summary

Optimind Pharma Corp. is a Canada-based emerging provider of psychedelic therapies for the masses. The Company helps people suffering from post-traumatic stress disorder (PTSD), anxiety, depression and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities. The Company also partnered with developers of psilocybin-associated treatments and products to further expand its treatment and program offerings. Its treatment programs are designed based on scientific research and specific modalities used in many different therapeutic practices. Each treatment program combines the use of psychedelic medicine with therapeutic processing and integration. It has two different types of treatments. Monotherapy and assisted therapy, all based on a Ketamine capsule. The effects are felt about 30 minutes after, and within two hours of taking the medicine, cognition is resorted to normal.

Sales per Business

CAD in Million2023Weight Delta
Ketamine and Cannabis Referrals
100.0 %
0 100.0 % -

Sales per region

CAD in Million2023Weight Delta
Canada
100.0 %
0 100.0 % -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 116,888,491 107,900,586 ( 92.31 %) 0 92.31 %

Shareholders

NameEquities%Valuation
4,190,630 4.272 % 20 953 $
3,390,000 3.456 % 16 950 $
2,000,000 2.039 % 10 000 $
233,497 0.2380 % 1 167 $
80,000 0.0816 % 400 $
50,000 0.0510 % 250 $

Company contact information

Optimind Pharma Corp.

77 King Street West Suite 3000

M5K 1G8, Toronto

+

http://optimindpharma.com
address Loon Energy Corporation(LNE.H)
  1. Stock Market
  2. Equities
  3. OMND Stock
  4. LNE.H Stock
  5. Company Loon Energy Corporation